Influenza vaccination and cardiovascular morbidity and mortality: Analysis of 292 383 patients

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 17, Issue 3, 2012, Pages 277-283

  Loomba, Rohit S ^a   Aggarwal, Saurabh ^b   Shah, Parinda H ^c   Arora, Rohit R ^b  

^a Children's Hospital of Wisconsin   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

Author keywords

all cause mortality; influenza; major adverse cardiac events; myocardial infarction; vaccination

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; INFLUENZA VACCINATION; META ANALYSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK REDUCTION;

CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84865146979     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248411429965     Document Type: Article

References (46)

1. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis. 1987 ; 136 (3). 550-555 (Pubitemid 18007351)
2. Eickhoff TC, Sherman IL, Serfling RE.. Observations on excess mortality associated with epidemic influenza. JAMA. 1961 ; 176 (9). 776-782
3. Housworth J, Langmuir AD. Excess mortality from epidemic influenza, 1957-1966. Am J Epidemiol. 1974 ; 100 (1). 40-48
4. Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol. 2004 ; 160 (5). 492-502 (Pubitemid 39166983)
5. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004 ; 351 (25). 2611-2618 (Pubitemid 39628582)
6. Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J. 2008 ; 29 (1). 96-103
7. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999 ; 340 (2). 115-126
8. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988 ; 2 (8618). 983-986
9. Pesonen E, El-Segaier M, Persson K, et al. Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes. Ther Adv Cardiovasc Dis. 2009 ; 3 (6). 447-454
10. Neumann F, Kastrati A, Miethke T, et al. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial. Lancet. 2001 ; 357 (9274). 2085-2089 (Pubitemid 32607452)
11. Zahn R, Schneider S, Frilling B, et al. Antibiotic therapy after acute myocardial infarction: a prospective randomized study. Circulation. 2003 ; 107 (9). 1253-1259 (Pubitemid 36314407)
12. Madjid M, Awan I, Ali M, Frazier L, Casscells W. Influenza and atherosclerosis: vaccination for cardiovascular disease prevention. Expert Opin Biol Ther. 2005 ; 5 (1). 91-96 (Pubitemid 40116482)
13. Gurevich VS. Influenza, autoimmunity and atherogenesis. Autoimmun Rev. 2005 ; 4 (2). 101-105 (Pubitemid 40255617)
14. Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis. 2008 ; 47 (2). 182-187 (Pubitemid 351920618)
15. Corrales-Medina VF, Serpa J, Rueda AM, et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore). 2009 ; 88 (3). 154-159
16. Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects. Eur Heart J. 2007 ; 28 (10). 1205-1210 (Pubitemid 47343835)
17. de Diego C, Vila-Córcoles A, Ochoa O, et al. Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease. Eur Heart J. 2009 ; 30 (2). 209-216
18. Ciszewski A, Bilinska ZT, Brydak LB, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J. 2008 ; 29 (11). 1350-1358 (Pubitemid 351806477)
19. Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, Sukonthasarn A. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J. 2011 ; 32 (14). 1730-1735
20. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003 ; 348 (14). 1322-1332 (Pubitemid 36384099)
21. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) study. Circulation. 2002 ; 105 (18). 2143-2147 (Pubitemid 34517156)
22. Puig-Barbera J, Díez-Domingo J, Varea AB, et al. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine. 2007 ; 25 (42). 7313-7321
23. Davis MM, Taubert K, Benin AL, et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation. 2006 ; 114 (14). 1549-1553 (Pubitemid 44527011)
24. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 2000 ; 102 (25). 3039-3045
25. Gurfinkel EP, de la Fuente RL. Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) registry. Tex Heart Inst J. 2004 ; 31 (1). 28-32 (Pubitemid 38366812)
26. Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006 ; 113 (19). 2363-2372 (Pubitemid 43947981)
27. Fiore A, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010 ; 59 (RR-8). 1-62
28. Gurevich VS, Pleskov VM, Levaya MV. Autoimmune nature of influenza atherogenicity. Ann N Y Acad Sci. 2005 ; 1050 (27). 410-416 (Pubitemid 41129460)
29. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation. 2001 ; 103 (18). 2283-2288 (Pubitemid 32433719)
30. Van Lenten BJ, Wagner AC, Anantharamaiah GM, et al. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation. 2002 ; 106 (9). 1127-1132 (Pubitemid 34970855)
31. Madjid M, Naghavi M, Litovsky S, Casscells SW. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation. 2003 ; 108 (22). 2730-2736 (Pubitemid 37498972)
32. Naghavi M, Wyde P, Litovsky S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation. 2003 ; 107 (5). 762-768 (Pubitemid 36222607)
33. Corrales-Medina VF, Suh KN, Rose G, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med. 2011 ; 8 (6). e1001048
34. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009 ; 9 (10). 601-610
35. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med. 1978 ; 148 (1). 335-340 (Pubitemid 8376500)
36. Minick CR, Fabricant CG, Fabricant J, Litrenta MM. Atheroarteriosclerosis induced by infection with a herpesvirus. Am J Pathol. 1979 ; 96 (3). 673-706 (Pubitemid 10223159)
37. Hajjar DP, Pomerantz KB, Falcone DJ, Weksler BB, Grant AJ. Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis. J Clin Invest. 1987 ; 80 (5). 1317-1321 (Pubitemid 18027773)
38. Siscovick DS, Raghunathan TE, Lin D, et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol. 2000 ; 152 (7). 674-677
39. Lavallee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke. 2002 ; 33 (2). 513-518 (Pubitemid 34123398)
40. Grau AJ, Fischer B, Barth C, Ling P, Lichy C, Buggle F. Influenza vaccination is associated with a reduced risk of stroke. Stroke. 2005 ; 36 (7). 1501-1506 (Pubitemid 40967520)
41. Armstrong BG, Mangtani P, Fletcher A, et al. Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ. 2004 ; 329 (7467). 660
42. Wang CS, Wang ST, Lai CT, Lin LJ, Chou P. Impact of influenza vaccination on major cause-specific mortality. Vaccine. 2007 ; 25 (7). 1196-1203 (Pubitemid 46027347)
43. Jackson LA, Yu O, Heckbert SR, Psaty BM, Malais D, Barlow WE. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol. 2002 ; 156 (7). 634-640
44. Meyers DG, et al. Influenza and pneumococcal vaccinations fail to prevent myocardial infarction. Heart Drug. 2004 ; 4 (2). 96-100 (Pubitemid 38608301)
45. Heffelfinger JD, Heckbert SR, Psaty BM, et al. Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin. 2006 ; 2 (4). 161-166 (Pubitemid 44422482)
46. Interim results: state-specific influenza vaccination coverage-United States, August 2010-February 2011. MMWR Morb Mortal Wkly Rep. 2011 ; 60 (22). 737-743